July
The 16th Annual Meeting of Japanese Society of Medical Oncology JSMO, July 19 - 21, 2018 - Kobe International Conference Center, Japan. Attendance: 3 posters and 1 oral presentation
- MH BRCA – Confident BRCA1/2 variant classification: using ACMG and public data for systematic molecular profiling
- Intelligent treatment decision support combining variant interpretation and phenotype analytics can transform healthcare
- Comprehensive treatment decision support of more than 1,000 patients by the medical device Molecular Health Guide®
- Evidence-based software for NGS in pancreatic cancer: first results from the PePaCaKa study
The 9th Annual Cancer Genomics Consortium CGC Meeting, August 6 – 8, 2018 - Nashville, TN, USA. Attendance: Molecular Health booth.
September
Molekularpathologie-Symposium, September 5-9, Gera, Germany. Attendance: lecture from Dr. Stephan Brock CTO of Molecular Health.
Heidelberger Myelomtage, September 21 – 23, 2018 – Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Attendance: Molecular Health booth.
ISPOR Asia Pacific 2018, September 8 – 11, 2018 – Kei Plaza Hotel, Tokyo, Japan. Attendance: Poster presentation.
- MH EFFECT® - A novel technology for the molecular analyses of real world outcomes/adverse event data.